LA JOLLA PHARMACEUTICAL CO (LJPC) has 110 open-market insider trades by 31 insiders since 2006. The most active filer is TANG Capital Partners L.P., CFO & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Kevin C. Tang | CFO10% Owner | — | 9 | $56.6M | 2022-08-22 |
| TANG Capital Partners L.P. | CFO10% Owner | — | 17 | $55.0M | 2021-12-01 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% Owner | — | 6 | $46.6M | 2019-01-08 |
| Martin P. Sutter | Dir | — | 6 | $25.2M | 2009-08-06 |
| TANG Capital Management LLC | CFO10% Owner | — | 6 | $20.2M | 2021-06-01 |
| Woodlands Health Ventures Fund Vii Lp Essex | 10% | — | 3 | $15.3M | 2009-08-06 |
| Alejandro Gonzalez | 10% | — | 10 | $12.3M | 2009-02-12 |
| Woodlands Health Ventures Fund Vi L. P. Essex | 10% | — | 4 | $10.6M | 2009-08-06 |
| James N. Topper | Dir | — | 2 | $5.4M | 2009-02-26 |
| Nader J. Naini | Dir | — | 1 | $5.0M | 2007-04-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David A. Ramsay | Director | Buy | $92K | 2021-12-02 |
| TANG Capital Partners L.P. | CFO & 10% Owner | Sell | $3.4M | 2021-11-29 |
| David A. Ramsay | Director | Buy | $32K | 2021-11-17 |
| TANG Capital Management LLC | CFO & 10% Owner | Buy | $2.2M | 2021-05-27 |
| David A. Ramsay | Director | Buy | $70K | 2021-05-24 |
| Kevin C. Tang | CFO & 10% Owner | Buy | $3.2M |
Companies that share insiders with LJPC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-05-24 |
| David A. Ramsay | Director | Buy | $4K | 2020-09-08 |
| Michael S. Hearne | CFO & 10% Owner | Buy | $2.2M | 2020-09-04 |
| David A. Ramsay | Director | Buy | $187K | 2020-08-20 |
| Kevin C. Tang | CFO & 10% Owner | Buy | $3.2M | 2020-08-12 |
| TANG Capital Partners L.P. | CFO & 10% Owner | Buy | $6.0M | 2020-06-02 |
| Kevin C. Tang | Director & 10% Owner | Buy | $1.7M | 2020-01-30 |
| Darryl Wellinghoff | Chief Commercial Officer | Buy | $25K | 2020-01-14 |
| Kevin C. Tang | Director & 10% Owner | Buy | $34.9M | 2020-01-09 |
| Lakhmir S. Chawla | Chief Medical Officer | Buy | $17K | 2019-01-29 |